ADAR1 Capital Management’s Nurix Therapeutics NRIX Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $355K | Buy |
31,200
+10,000
| +47% | +$114K | 0.05% | 128 |
|
2025
Q1 | $252K | Buy |
21,200
+10,200
| +93% | +$121K | 0.05% | 131 |
|
2024
Q4 | $207K | Buy |
+11,000
| New | +$207K | 0.04% | 147 |
|
2024
Q3 | – | Sell |
-3,500
| Closed | -$73K | – | 291 |
|
2024
Q2 | $73K | Sell |
3,500
-32,108
| -90% | -$670K | 0.01% | 171 |
|
2024
Q1 | $523K | Buy |
+35,608
| New | +$523K | 0.12% | 75 |
|